Project Grant R44DK085741

Federal Project Grant Award Summary Aplos Medical Inc. received a $570,706 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 2, 2025 through August 31, 2027. The company is conducting commercialization activities to bring its Omega PF device to market—a novel endoscopic treatment for drug-failed gastroesophageal reflux disease...

This $1 million cooperative agreement from the National Science Foundation will support Reflodx, Inc. in developing a novel, noninvasive device to detect and characterize the presence or absence of a bolus in the upper esophagus. Under the NSF Technology, Innovation, and Partnerships program, Reflodx will continue work on a patented pulse-echo ultrasound technology using proprietary algorithms to create an acoustic signature that can differentiate a bolus in the esophagus. Over the two-year...

Teliatry Inc. received a $768,138 project grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering to develop a minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain management. The grant was awarded under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. Through this award, Teliatry will engineer the world's smallest (0.75cc), most cost-effective...

Sentire Medical Systems, Inc. was awarded a $256,000 National Science Foundation Project Grant to develop an intraoperative monitoring device to detect bowel injuries during laparoscopic surgical procedures. The goal of the NSF Technology, Innovation, and Partnerships program is to advance science and engineering research leading to breakthrough technologies that address national challenges. Through this award, Sentire Medical will characterize gases present during laparoscopic surgery to...

Federal Grant Award Summary Safeguard Surgical, Inc. received $813,000 in Small Business Innovation Research (SBIR) Phase I funding from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), awarded September 18, 2025, with a completion date of August 31, 2026. The company is developing LeakGuard, a biodegradable barrier device designed to prevent anastomotic leakage (AL)—a serious complication affecting up to 22% of esophageal cancer patients undergoing...

Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Intailor Bariatrics, LLC a Project Grant of $325,408 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 8, 2025, with a completion date of August 31, 2026. The grant supports development and advancement of an automated endoscopic gastroplasty device designed to provide a minimally invasive alternative to traditional bariatric...

The federal Project Grant award R43DK137616 for $275,766.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds Biosurfaces Inc., a for-profit medical device company, to develop and evaluate an implantable, electrospun cell chamber device loaded with human pancreatic islets. The device aims to provide an immune-protected environment to support...

The Spinex Inc. was awarded a $4,719,091 Project Grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to develop and clinically validate a transcutaneous electrical spinal cord neuromodulation (TESCON) device to mitigate symptoms of neurogenic bladder resulting from spinal cord injury. The award, made under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support Spinex in building a commercial...

Revmedica Inc. received a $275,881 Small Business Innovation Research Phase I Project Grant from the National Science Foundation on May 1, 2021 to develop a hybrid surgical stapler with tissue sensing technology. The NSF Engineering Division grant program supports innovative engineering research and development with the goal of improving quality of life and U.S. economic strength. Under this award, Revmedica will leverage tissue sensing capabilities to enhance surgical stapling devices used in...

The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...